Warming cryopreserved human oocytes Pregnancy and Childbirth
Conditions
Interventions
All participants undergo controlled ovarian stimulation between day 12 and 20 of their menstrual cycle using gonadotropin-releasing hormone analogs in combination with a graded gonadotropin administra
Sponsors
GynePro Medical
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Infertile patients 2. Undergoing to fertility treatments via Intracytoplasmic Sperm injection (ICSI) 3. Aged 18 years and over 4. Female
Exclusion criteria
Exclusion criteria: Patients undergoing to preimplanatation genetic screening (PGS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival rate (number of embryos surviving per number of embryo warmed) is measured using observation a optical microscope one hour after thawing. | — |
Secondary
| Measure | Time frame |
|---|---|
| Implantation rate (number of embryos implanted per number of embryos transferred in utero) is measured using ultrasound observation of gestational sacs at 30 days after the in-utero embryo transfer. | — |
Countries
Italy
Outcome results
None listed